-

Rapid Medical Announces Eitan Havis as International President

Mr. Havis will Lead Commercialization from Europe to Asia

YOKNEAM, Israel & MIAMI--(BUSINESS WIRE)--Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International. Mr. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in Europe, Asia, and other geographies.

Mr. Havis brings 20 years of sales leadership experience for both growth-stage and large medical device companies. He joined Rapid Medical in 2013 as the Vice President of Sales and Marketing. During his tenure, he helped to grow the company from an early-stage start-up to a well-funded commercial operation. With Mr. Havis’s leadership, the company has launched 3 product franchises, each providing neurointerventionalist with greater control over procedural outcomes than previous offerings and gaining adoption in thousands of hospitals.

“Eitan has been a crucial leader in growing the company from its infancy,” commented Ronen Eckhouse, CEO and co-founder of Rapid Medical. “His leadership & professional expertise will enable us to further develop and expand our international presence.”

“Rapid Medical’s devices provide interventionalists with enhanced control inside of the vessel, allowing them to tailor the treatment to each patient,” adds Eitan Havis, President, International, for Rapid Medical. “I am continuously inspired by our talented team as we bring these advanced solutions to physicians across the globe.”

About Rapid Medical

Rapid Medical develops the premier, responsive interventional devices for neurovascular diseases such as ischemic and hemorrhagic stroke. Utilizing novel manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the intravascular environment and have greater control over procedural outcomes. TIGERTRIEVER™17 and 21, COMANECI™ and COLUMBUS™/DRIVEWIRE are CE marked and FDA cleared. TIGERTRIEVER™13 and XL are also CE marked. More information is available at www.rapid-medical.com.

Contacts

Ronen Eckhouse
+972-72-2503331
ronen@rapid-medical.com

Rapid Medical


Release Summary
Rapid Medical announces Eitan Havis as President, International, to lead commercialization efforts for the first responsive stroke devices.

Contacts

Ronen Eckhouse
+972-72-2503331
ronen@rapid-medical.com

Social Media Profiles
More News From Rapid Medical

Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions

SOUTHLAKE, Texas & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical completes DISTALS enrollment for TIGERTRIEVER 13 for DMVO stroke, backed by interim safety data and demand for distal-specific devices....

Rapid Medical™ Appoints Industry Veteran Nir Nimrodi to Its Board of Directors

SOUTHLAKE, Texas & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical adds Nir Nimrodi to Board, fueling global expansion and breakthroughs in neuro intervention and stroke treatment.....

Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval

SOUTHLAKE, Texas & MARSEILLE, France--(BUSINESS WIRE)--Clinical success and MDR approval position DRIVEWIRE™ 24 as a next-generation access technology set to reshape neurovascular practice....
Back to Newsroom